|
|
Article: XIEHE GROUP SETS UP SHENZHEN GENETIC ENGINEERING SUBSIDIARY
- Article from:
- AsiaInfo Services
- Article date:
- August 11, 2008
|
Copyright informationProvided by ProQuest LLC. (Hide copyright information)
|
AsiaInfo Services
08-11-2008
Xiehe Group Sets Up Shenzhen Genetic Engineering Subsidiary
SHENZHEN, Aug 11, 2008 (SinoCast via COMTEX) -- Chinese pharmaceutical producer Shenyang Xiehe Group Co., Ltd. yesterday established a wholly-owned genetic engineering subsidiary in Shenzhen, a boomtown neighboring Hong Kong.
The company intends to shift R&D of antitumor drugs and drugs for prevention and treatment of leukemia, one of its key works, to Shenzhen, said its chairman Chen Juyu. And it plans to locate its R&D base and international sales base, which would help the company in overseas expansion, in the city.
Based in Shenyang City, Liaoning Province, Northeast China, Xiehe Group is ...
Related newspaper, magazine, and journal articles:
|